Cystic fibrosis in the modern therapeutic era: Give the shower a thought!

J Cyst Fibros. 2019 Nov;18(6):e56-e57. doi: 10.1016/j.jcf.2019.03.004. Epub 2019 Mar 21.

Abstract

Fifty-two meshes of e-flow rapid® were characterized for tobramycin delivery with a laser diffractometer after 6 months of home use by cystic fibrosis patients treated with various nebulized drugs. Three meshes were out of order and 30 considered to be defective for tobramycin delivery. The use of the specific mesh cleaning shower system permitted 14 defective meshes to be in the expected range of nebulized volume.

Keywords: Cystic fibrosis; In vitro study; Mesh-nebulizer; Tobramycin.

MeSH terms

  • Administration, Inhalation
  • Anti-Bacterial Agents / therapeutic use
  • Cystic Fibrosis / drug therapy*
  • Equipment Contamination / prevention & control
  • Equipment Failure Analysis
  • Equipment Failure*
  • Humans
  • Nebulizers and Vaporizers* / microbiology
  • Nebulizers and Vaporizers* / standards
  • Pseudomonas Infections / prevention & control*
  • Self Care / instrumentation
  • Self Care / methods
  • Tobramycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Tobramycin